Pfizer CT.gov Call Center

CONTACT

Lead Sponsor

Pfizer

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•Patients older than 18 years of age at inclusion.
•Patients with clinical diagnosis of moderate-to-severe chronic atopic dermatitis (also referred to as atopic eczema) at inclusion according to the investigator and eligible for abrocitinib according to its marketing approval.
•Patients that have been informed of the study procedures and have signed the consent.

•Patients for whom abrocitinib is contraindicated.
•Patients unable to follow and respect the study procedures and judged inapt to respond to the questions required for the study due to linguistical, psychological, social, or geographical reasons.
•Patients not affiliated to the French social security system.
•Patients deprived of liberty, under guardianship, or unable to provide oral consent.
•Patients participating in a clinical study assessing a medicinal treatment (patients can participate in registries and observatories).